Increased Expression of Plasma and CD4+ T Lymphocyte Costimulatory Molecule CD26 in Adult Patients with Allergic Asthma

被引:0
作者
Samantha W. M. Lun
C. K. Wong
Fanny W. S. Ko
David S. C. Hui
Christopher W. K. Lam
机构
[1] The Chinese University of Hong Kong,Department of Chemical Pathology
[2] Prince of Wales Hospital,Department of Medicine and Therapeutics
[3] The Chinese University of Hong Kong,Department of Chemical Pathology
[4] Prince of Wales Hospital,undefined
[5] The Chinese University of Hong Kong,undefined
[6] Prince of Wales Hospital,undefined
来源
Journal of Clinical Immunology | 2007年 / 27卷
关键词
allergy; asthma; costimulatory molecules; CD26; T lymphocytes;
D O I
暂无
中图分类号
学科分类号
摘要
CD26, which is a costimulatory molecule and peptidase, is responsible for the degradation of interferon (IFN)-γ-induced chemokines. To elucidate the immunopathological role of CD26 in allergic asthma, we investigated plasma soluble CD26 (sCD26) concentration and its cell surface expression on lymphocytes, monocytes, CD4+ T helper, CD8+ T suppressor plus cytotoxic T, invariant natural killer T (iNKT), and CD19+ B lymphocytes in allergic asthmatic patients. Plasma sCD26 was significantly elevated in asthmatic patients regardless of inhaled corticosteroid treatment (all P < 0.05). Cell surface expression of CD26 was significantly up-regulated on lymphocytes, especially on CD4+ and iNKT lymphocytes (all P < 0.05), but not on other cell types. Significant positive correlations were found between sCD26 and the percentage of eosinophils, Th2-related chemokines CCL5 and CCL22, and costimulatory molecule sCTLA-4 (all P < 0.05). In conclusion, the aberrant expression of CD26 may contribute to the inflammatory process and Th2 predominance in the immunopathogenesis of allergic asthma.
引用
收藏
页码:430 / 437
页数:7
相关论文
共 82 条
  • [1] Yssel H(2000)Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases Int Arch Allergy Immunol 121 10-8
  • [2] Groux H(2003)The role of T lymphocytes in the pathogenesis of asthma J Allergy Clin Immunol 111 450-63
  • [3] Larche M(1998)Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus Clin Exp Allergy 28 110-20
  • [4] Robinson DS(2001)Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties Blood 98 3554-61
  • [5] Kay AB(2003)I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Crit Rev Clin Lab Sci 40 209-94
  • [6] Van DVV(1993)Dipeptidyl peptidase IV (CD26) and aminopeptidase N (CD13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences FEBS 336 61-4
  • [7] Wierenga-Wolf AF(1998)The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 746-54
  • [8] Driaansen-Soeting PW(2006)Circulating levels of soluble CD26 are associated with phobic anxiety in women Prog Neuropsychopharmacol Biol Psychiatry 30 1334-6
  • [9] Proost P(2006)Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies Arthritis Res Ther 8 R107-60
  • [10] Schutyser E(1997)Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells Immunology 91 354-55